120 related articles for article (PubMed ID: 8764745)
1. Role of p53 immunohistochemistry in differentiating reactive gliosis from malignant astrocytic lesions.
Yaziji H; Massarani-Wafai R; Gujrati M; Kuhns JG; Martin AW; Parker JC
Am J Surg Pathol; 1996 Sep; 20(9):1086-90. PubMed ID: 8764745
[TBL] [Abstract][Full Text] [Related]
2. p53 in nonneoplastic central nervous system lesions: an immunohistochemical and genetic sequencing study.
Kurtkaya-Yapicier O; Scheithauer BW; Hebrink D; James CD
Neurosurgery; 2002 Nov; 51(5):1246-54; discussion 1254-5. PubMed ID: 12383370
[TBL] [Abstract][Full Text] [Related]
3. p53 protein overexpression in astrocytic neoplasms.
Cho MY; Jung SH; Kim TS
Yonsei Med J; 1995 Dec; 36(6):521-6. PubMed ID: 8599254
[TBL] [Abstract][Full Text] [Related]
4. J1-31 protein expression in astrocytes and astrocytomas.
Shuangshoti S; Thorner PS; Ruangvejvorachai P; Saha B; Groshen S; Taylor CR; Malhotra S; Imam SA
Neuropathology; 2009 Oct; 29(5):521-7. PubMed ID: 19019178
[TBL] [Abstract][Full Text] [Related]
5. WT1 expression distinguishes astrocytic tumor cells from normal and reactive astrocytes.
Schittenhelm J; Mittelbronn M; Nguyen TD; Meyermann R; Beschorner R
Brain Pathol; 2008 Jul; 18(3):344-53. PubMed ID: 18371184
[TBL] [Abstract][Full Text] [Related]
6. Receptor tyrosine kinase expression in astrocytic lesions: similar features in gliosis and glioma.
Kristt DA; Reedy E; Yarden Y
Neurosurgery; 1993 Jul; 33(1):106-15. PubMed ID: 7689190
[TBL] [Abstract][Full Text] [Related]
7. Role of gemistocytes in astrocytoma progression.
Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical pattern of P53 protein in human astrocytic tumors.
Howng SL; Hwang SL; Chai CY; Lin HJ
Kaohsiung J Med Sci; 1996 May; 12(5):279-84. PubMed ID: 8676433
[TBL] [Abstract][Full Text] [Related]
9. p53 protein in pediatric malignant astrocytomas: a study of 21 patients.
Bhattacharjee MB; Bruner JM
J Neurooncol; 1997 May; 32(3):225-33. PubMed ID: 9049884
[TBL] [Abstract][Full Text] [Related]
10. MIB-1 and p53 immunocytochemistry for differentiating pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas in children and young adults.
Matsumoto T; Fujii T; Yabe M; Oka K; Hoshi T; Sato K
Histopathology; 1998 Nov; 33(5):446-52. PubMed ID: 9839169
[TBL] [Abstract][Full Text] [Related]
11. Expression and mutation analysis of the p53 gene in astrocytoma.
Hwang SL; Hong YR; Sy WD; Chai CY; Lin HJ; Howng SL
J Formos Med Assoc; 1999 Jan; 98(1):31-8. PubMed ID: 10063271
[TBL] [Abstract][Full Text] [Related]
12. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
[TBL] [Abstract][Full Text] [Related]
13. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
Lang FF; Miller DC; Koslow M; Newcomb EW
J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of basic fibroblast growth factor in astrocytomas.
Zagzag D; Miller DC; Sato Y; Rifkin DB; Burstein DE
Cancer Res; 1990 Nov; 50(22):7393-8. PubMed ID: 2171762
[TBL] [Abstract][Full Text] [Related]
15. p-CREB expression in human gliomas: potential use in the differential diagnosis between astrocytoma and oligodendroglioma.
Barresi V; Mondello S; Branca G; Rajan TS; Vitarelli E; Tuccari G
Hum Pathol; 2015 Feb; 46(2):231-8. PubMed ID: 25476123
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical detection of p53 in human gliomas.
Bruner JM; Saya H; Moser RP
Mod Pathol; 1991 Sep; 4(5):671-4. PubMed ID: 1758878
[TBL] [Abstract][Full Text] [Related]
17. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
[TBL] [Abstract][Full Text] [Related]
18. In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging.
De Stefano N; Caramanos Z; Preul MC; Francis G; Antel JP; Arnold DL
Ann Neurol; 1998 Aug; 44(2):273-8. PubMed ID: 9708554
[TBL] [Abstract][Full Text] [Related]
19. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
20. Gliosis versus glioma?: don't grade until you know.
Rivera-Zengotita M; Yachnis AT
Adv Anat Pathol; 2012 Jul; 19(4):239-49. PubMed ID: 22692287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
